Share Price and Basic Stock Data
Last Updated: January 10, 2026, 4:17 am
| PEG Ratio | 3.06 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Gillette India Ltd operates within the personal care sector, focusing primarily on grooming products. The company reported a market capitalization of ₹26,429 Cr, with its share price currently standing at ₹8,110. In the most recent quarter ending September 2023, Gillette India recorded sales of ₹668 Cr, reflecting a year-on-year increase from ₹620 Cr in September 2022. The revenue trajectory showcases a steady growth, with sales for the trailing twelve months (TTM) amounting to ₹2,971 Cr. The quarterly sales data highlights a consistent pattern, with sales figures generally hovering around the ₹619 Cr mark throughout the early part of FY 2024 before rising significantly in subsequent quarters. The company’s operating profit margin (OPM) stood at 26%, underscoring its ability to maintain profitability amid fluctuating sales. This consistent revenue growth is indicative of Gillette’s strong market presence and brand loyalty in the personal care industry.
Profitability and Efficiency Metrics
Gillette India Ltd has demonstrated robust profitability metrics, with a reported net profit of ₹574 Cr for the trailing twelve months. The company’s return on equity (ROE) stood impressively at 41.6%, while the return on capital employed (ROCE) reached 56.1%, well above the typical sector averages. The operating profit for the quarter ending September 2023 was ₹138 Cr, with an operating profit margin (OPM) of 21%, showing resilience in maintaining profitability despite rising expenses. The interest coverage ratio (ICR) was exceptionally high at 75.73x, indicating the company’s strong ability to meet its interest obligations without relying on debt, which is recorded at ₹0 Cr. This financial health is complemented by a cash conversion cycle (CCC) of -17 days, reflecting efficient working capital management. The combination of high profitability and operational efficiency positions Gillette India favorably within the competitive landscape of personal care products.
Balance Sheet Strength and Financial Ratios
Gillette India’s balance sheet exhibits significant strength, characterized by total assets of ₹1,918 Cr and zero borrowings, indicating a debt-free status. The company reported reserves of ₹1,130 Cr, reflecting its solid internal capital generation capabilities. The equity capital remained constant at ₹33 Cr over the years, while the book value per share, including revaluation reserves, stood at ₹313.93. The current ratio of 1.64 and a quick ratio of 1.06 suggest that Gillette maintains sufficient liquidity to meet its short-term obligations. Financial ratios, such as the price-to-book value (P/BV) at 24.31x, indicate that the stock is trading at a premium compared to typical sector valuations. Furthermore, the return on assets (ROA) was reported at 21.77%, showcasing effective asset utilization. This robust balance sheet and favorable financial ratios underscore Gillette’s capacity to sustain growth and navigate potential market challenges effectively.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Gillette India Ltd reflects a strong commitment from its promoters, who hold 75% of the company’s shares. This stability is crucial for investor confidence, especially in a market that values long-term strategic vision. Foreign institutional investors (FIIs) have gradually increased their stake from 2.50% in December 2022 to 5.01% by September 2025, indicating growing interest from external investors. Domestic institutional investors (DIIs) also hold a significant portion at 9.15%. The number of shareholders has risen to 52,984, highlighting an expanding retail investor base. However, the public holding has fluctuated slightly, currently standing at 10.83%. This distribution of shareholding suggests a healthy mix of institutional and retail investors, which is generally seen as a positive signal in terms of governance and operational transparency.
Outlook, Risks, and Final Insight
The outlook for Gillette India Ltd appears positive, driven by sustained revenue growth and strong profitability metrics. However, potential risks include market volatility and competitive pressures within the personal care sector, which could impact margins. Additionally, fluctuations in raw material costs may pose challenges to maintaining operational efficiency. While the company has effectively managed its expenses, any significant increase could affect profit margins. Another concern is the reliance on brand loyalty in a market that is increasingly favoring innovative and sustainable products. Nevertheless, Gillette’s strong financial position, robust operational metrics, and strategic focus on brand equity provide a solid foundation for navigating these challenges. If the company continues to innovate and adapt to changing consumer preferences, it may further solidify its market leadership.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,449 Cr. | 290 | 334/190 | 75.9 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 44.2 Cr. | 25.7 | 37.0/23.3 | 86.7 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 115 Cr. | 120 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 592 Cr. | 390 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 9,570 Cr. | 261 | 423/259 | 26.2 | 55.8 | 1.34 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 70,694.00 Cr | 1,871.39 | 59.44 | 112.70 | 0.77% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 620 | 619 | 619 | 619 | 668 | 639 | 681 | 645 | 782 | 686 | 767 | 707 | 811 |
| Expenses | 484 | 493 | 485 | 476 | 530 | 483 | 519 | 470 | 591 | 503 | 542 | 496 | 603 |
| Operating Profit | 136 | 126 | 134 | 144 | 138 | 157 | 161 | 176 | 190 | 183 | 226 | 210 | 208 |
| OPM % | 22% | 20% | 22% | 23% | 21% | 25% | 24% | 27% | 24% | 27% | 29% | 30% | 26% |
| Other Income | 3 | 3 | 12 | 5 | 9 | 7 | 6 | 5 | 7 | 9 | 12 | 7 | 9 |
| Interest | 0 | 3 | 1 | 3 | 1 | 4 | 4 | 4 | 1 | 4 | 3 | 1 | 4 |
| Depreciation | 18 | 19 | 22 | 22 | 20 | 21 | 21 | 21 | 19 | 21 | 25 | 20 | 20 |
| Profit before tax | 120 | 106 | 123 | 124 | 125 | 139 | 143 | 155 | 177 | 167 | 210 | 195 | 193 |
| Tax % | 28% | 30% | 16% | 26% | 26% | 25% | 31% | 25% | 25% | 25% | 24% | 25% | 25% |
| Net Profit | 87 | 74 | 103 | 92 | 93 | 104 | 99 | 116 | 133 | 126 | 159 | 146 | 144 |
| EPS in Rs | 26.63 | 22.85 | 31.52 | 28.16 | 28.45 | 31.90 | 30.41 | 35.59 | 40.82 | 38.66 | 48.70 | 44.71 | 44.08 |
Last Updated: January 2, 2026, 6:02 pm
Below is a detailed analysis of the quarterly data for Gillette India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 811.00 Cr.. The value appears strong and on an upward trend. It has increased from 707.00 Cr. (Jun 2025) to 811.00 Cr., marking an increase of 104.00 Cr..
- For Expenses, as of Sep 2025, the value is 603.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 496.00 Cr. (Jun 2025) to 603.00 Cr., marking an increase of 107.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 208.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Jun 2025) to 208.00 Cr., marking a decrease of 2.00 Cr..
- For OPM %, as of Sep 2025, the value is 26.00%. The value appears to be declining and may need further review. It has decreased from 30.00% (Jun 2025) to 26.00%, marking a decrease of 4.00%.
- For Other Income, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Jun 2025) to 9.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Jun 2025) to 4.00 Cr., marking an increase of 3.00 Cr..
- For Depreciation, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 20.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 193.00 Cr.. The value appears to be declining and may need further review. It has decreased from 195.00 Cr. (Jun 2025) to 193.00 Cr., marking a decrease of 2.00 Cr..
- For Tax %, as of Sep 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 25.00%.
- For Net Profit, as of Sep 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 146.00 Cr. (Jun 2025) to 144.00 Cr., marking a decrease of 2.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 44.08. The value appears to be declining and may need further review. It has decreased from 44.71 (Jun 2025) to 44.08, marking a decrease of 0.63.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:45 am
| Metric | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025n n 9m | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,662 | 1,875 | 1,755 | 1,733 | 1,677 | 1,862 | 1,679 | 1,982 | 2,256 | 2,477 | 2,633 | 2,235 | 2,971 |
| Expenses | 1,589 | 1,684 | 1,448 | 1,348 | 1,290 | 1,478 | 1,319 | 1,522 | 1,773 | 1,937 | 1,995 | 1,635 | 2,144 |
| Operating Profit | 73 | 191 | 306 | 385 | 387 | 384 | 360 | 460 | 483 | 540 | 638 | 600 | 826 |
| OPM % | 4% | 10% | 17% | 22% | 23% | 21% | 21% | 23% | 21% | 22% | 24% | 27% | 28% |
| Other Income | 38 | 68 | 50 | 34 | 8 | 11 | 11 | 32 | 7 | 22 | 20 | 27 | 36 |
| Interest | 0 | 5 | 6 | 7 | 7 | 8 | 5 | 5 | 11 | 8 | 13 | 9 | 13 |
| Depreciation | 33 | 39 | 30 | 38 | 42 | 48 | 51 | 58 | 68 | 81 | 83 | 64 | 85 |
| Profit before tax | 78 | 215 | 320 | 374 | 345 | 339 | 314 | 429 | 411 | 473 | 562 | 554 | 765 |
| Tax % | 34% | 26% | 33% | 32% | 34% | 25% | 27% | 28% | 30% | 25% | 27% | 25% | |
| Net Profit | 51 | 158 | 214 | 253 | 229 | 253 | 230 | 310 | 289 | 356 | 412 | 418 | 574 |
| EPS in Rs | 15.78 | 48.53 | 65.73 | 77.67 | 70.29 | 77.62 | 70.64 | 95.25 | 88.79 | 109.15 | 126.35 | 128.17 | 176.15 |
| Dividend Payout % | 95% | 31% | 60% | 211% | 33% | 57% | 69% | 125% | 78% | 78% | 103% | 87% |
YoY Net Profit Growth
| Year |
|---|
| YoY Net Profit Growth (%) |
| Change in YoY Net Profit Growth (%) |
No data available for trend analysis.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 4% |
| 3 Years: | 4% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 10% |
| 3 Years: | 11% |
| TTM: | 37% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 14% |
| 3 Years: | 25% |
| 1 Year: | 17% |
| Return on Equity | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 36% |
| 3 Years: | 39% |
| Last Year: | 42% |
Last Updated: September 4, 2025, 9:25 pm
Balance Sheet
Last Updated: December 4, 2025, 12:51 am
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 |
| Reserves | 611 | 710 | 904 | 468 | 662 | 746 | 879 | 756 | 829 | 956 | 939 | 991 | 1,130 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 411 | 468 | 488 | 498 | 515 | 432 | 441 | 606 | 758 | 927 | 859 | 895 | 987 |
| Total Liabilities | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,918 | 2,149 |
| Fixed Assets | 173 | 156 | 178 | 214 | 264 | 300 | 296 | 310 | 363 | 389 | 347 | 342 | 322 |
| CWIP | 61 | 63 | 88 | 63 | 40 | 25 | 21 | 72 | 65 | 32 | 26 | 17 | 31 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 821 | 991 | 1,158 | 721 | 904 | 886 | 1,034 | 1,013 | 1,191 | 1,494 | 1,458 | 1,558 | 1,797 |
| Total Assets | 1,054 | 1,210 | 1,424 | 998 | 1,209 | 1,210 | 1,352 | 1,395 | 1,619 | 1,916 | 1,831 | 1,918 | 2,149 |
Below is a detailed analysis of the balance sheet data for Gillette India Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 33.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 33.00 Cr..
- For Reserves, as of Sep 2025, the value is 1,130.00 Cr.. The value appears strong and on an upward trend. It has increased from 991.00 Cr. (Mar 2025) to 1,130.00 Cr., marking an increase of 139.00 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 987.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 895.00 Cr. (Mar 2025) to 987.00 Cr., marking an increase of 92.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,149.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,918.00 Cr. (Mar 2025) to 2,149.00 Cr., marking an increase of 231.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 322.00 Cr.. The value appears to be declining and may need further review. It has decreased from 342.00 Cr. (Mar 2025) to 322.00 Cr., marking a decrease of 20.00 Cr..
- For CWIP, as of Sep 2025, the value is 31.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2025) to 31.00 Cr., marking an increase of 14.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,797.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,558.00 Cr. (Mar 2025) to 1,797.00 Cr., marking an increase of 239.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,149.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,918.00 Cr. (Mar 2025) to 2,149.00 Cr., marking an increase of 231.00 Cr..
Notably, the Reserves (1,130.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025n n 9m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 73.00 | 191.00 | 306.00 | 385.00 | 387.00 | 384.00 | 360.00 | 460.00 | 483.00 | 540.00 | 638.00 | 600.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Jun 2014 | Jun 2015 | Jun 2016 | Jun 2017 | Jun 2018 | Jun 2019 | Jun 2020 | Jun 2021 | Jun 2022 | Jun 2023 | Jun 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 20 | 23 | 23 | 27 | 38 | 36 | 41 | 36 | 43 | 47 | 38 | 62 |
| Inventory Days | 104 | 87 | 104 | 103 | 105 | 104 | 136 | 152 | 130 | 127 | 131 | 181 |
| Days Payable | 116 | 116 | 137 | 150 | 173 | 126 | 138 | 169 | 193 | 209 | 212 | 260 |
| Cash Conversion Cycle | 9 | -6 | -10 | -19 | -30 | 15 | 40 | 19 | -20 | -35 | -43 | -17 |
| Working Capital Days | 27 | 49 | -10 | -17 | -18 | 15 | 35 | 14 | -0 | -4 | -7 | 13 |
| ROCE % | 12% | 35% | 39% | 54% | 60% | 48% | 38% | 51% | 51% | 52% | 59% | 56% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Nippon India Multi Cap Fund | 261,119 | 0.45 | 226.77 | 231,798 | 2025-12-15 04:02:53 | 12.65% |
| ICICI Prudential Smallcap Fund | 252,882 | 2.6 | 219.62 | 218,670 | 2025-12-15 05:14:53 | 15.65% |
| Nippon India Large Cap Fund | 230,361 | 0.4 | 200.06 | 221,872 | 2025-12-15 05:14:53 | 3.83% |
| Aditya Birla Sun Life ELSS Tax Saver Fund | 207,163 | 1.15 | 179.91 | 464,089 | 2025-12-07 06:45:34 | -55.36% |
| Aditya Birla Sun Life MNC Fund | 78,341 | 1.87 | 68.04 | N/A | N/A | N/A |
| ICICI Prudential Large Cap Fund | 59,209 | 0.07 | 51.42 | N/A | N/A | N/A |
| Aditya Birla Sun Life Balanced Advantage Fund | 50,000 | 0.49 | 43.42 | N/A | N/A | N/A |
| Tata India Consumer Fund | 45,000 | 1.46 | 39.08 | N/A | N/A | N/A |
| ICICI Prudential FMCG Fund | 39,072 | 1.73 | 33.93 | N/A | N/A | N/A |
| PGIM India Flexi Cap Fund | 29,333 | 0.4 | 25.47 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Jun 24 | Jun 23 | Jun 22 | Jun 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 128.17 | 126.35 | 109.15 | 88.79 | 95.25 |
| Diluted EPS (Rs.) | 128.17 | 126.35 | 109.15 | 88.79 | 95.25 |
| Cash EPS (Rs.) | 147.88 | 151.68 | 133.90 | 109.75 | 112.89 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 313.93 | 298.03 | 303.42 | 264.25 | 242.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 313.93 | 298.03 | 303.42 | 264.25 | 242.10 |
| Dividend / Share (Rs.) | 112.00 | 130.00 | 85.00 | 69.00 | 119.00 |
| Revenue From Operations / Share (Rs.) | 685.74 | 807.94 | 760.06 | 692.28 | 616.58 |
| PBDIT / Share (Rs.) | 192.37 | 200.53 | 172.25 | 150.42 | 151.04 |
| PBIT / Share (Rs.) | 172.65 | 175.17 | 147.49 | 129.44 | 133.39 |
| PBT / Share (Rs.) | 170.04 | 172.52 | 145.10 | 126.21 | 131.78 |
| Net Profit / Share (Rs.) | 128.16 | 126.33 | 109.14 | 88.78 | 95.24 |
| PBDIT Margin (%) | 28.05 | 24.81 | 22.66 | 21.72 | 24.49 |
| PBIT Margin (%) | 25.17 | 21.68 | 19.40 | 18.69 | 21.63 |
| PBT Margin (%) | 24.79 | 21.35 | 19.09 | 18.23 | 21.37 |
| Net Profit Margin (%) | 18.68 | 15.63 | 14.35 | 12.82 | 15.44 |
| Return on Networth / Equity (%) | 40.82 | 42.38 | 35.96 | 33.59 | 39.33 |
| Return on Capital Employeed (%) | 49.53 | 53.26 | 43.68 | 44.66 | 50.06 |
| Return On Assets (%) | 21.77 | 22.48 | 18.56 | 17.98 | 22.24 |
| Asset Turnover Ratio (%) | 1.19 | 1.41 | 1.41 | 1.50 | 1.46 |
| Current Ratio (X) | 1.64 | 1.56 | 1.53 | 1.43 | 1.46 |
| Quick Ratio (X) | 1.06 | 1.04 | 1.03 | 0.87 | 0.76 |
| Inventory Turnover Ratio (X) | 5.26 | 6.52 | 1.73 | 1.60 | 1.48 |
| Dividend Payout Ratio (NP) (%) | 85.81 | 106.84 | 65.04 | 77.71 | 138.57 |
| Dividend Payout Ratio (CP) (%) | 74.37 | 88.98 | 53.01 | 62.85 | 116.91 |
| Earning Retention Ratio (%) | 14.19 | -6.84 | 34.96 | 22.29 | -38.57 |
| Cash Earning Retention Ratio (%) | 25.63 | 11.02 | 46.99 | 37.15 | -16.91 |
| Interest Coverage Ratio (X) | 73.67 | 75.73 | 72.25 | 46.55 | 93.76 |
| Interest Coverage Ratio (Post Tax) (X) | 50.08 | 48.71 | 46.78 | 28.48 | 60.12 |
| Enterprise Value (Cr.) | 25719.18 | 23131.91 | 16107.66 | 16033.26 | 18343.17 |
| EV / Net Operating Revenue (X) | 11.51 | 8.79 | 6.50 | 7.11 | 9.13 |
| EV / EBITDA (X) | 41.02 | 35.40 | 28.69 | 32.71 | 37.27 |
| MarketCap / Net Operating Revenue (X) | 11.70 | 8.97 | 6.69 | 7.24 | 9.21 |
| Retention Ratios (%) | 14.18 | -6.84 | 34.95 | 22.28 | -38.57 |
| Price / BV (X) | 25.55 | 24.31 | 16.75 | 18.96 | 23.46 |
| Price / Net Operating Revenue (X) | 11.70 | 8.97 | 6.69 | 7.24 | 9.21 |
| EarningsYield | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
After reviewing the key financial ratios for Gillette India Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Jun 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
- For Diluted EPS (Rs.), as of Mar 25, the value is 128.17. This value is within the healthy range. It has increased from 126.35 (Jun 24) to 128.17, marking an increase of 1.82.
- For Cash EPS (Rs.), as of Mar 25, the value is 147.88. This value is within the healthy range. It has decreased from 151.68 (Jun 24) to 147.88, marking a decrease of 3.80.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 313.93. It has increased from 298.03 (Jun 24) to 313.93, marking an increase of 15.90.
- For Dividend / Share (Rs.), as of Mar 25, the value is 112.00. This value exceeds the healthy maximum of 3. It has decreased from 130.00 (Jun 24) to 112.00, marking a decrease of 18.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 685.74. It has decreased from 807.94 (Jun 24) to 685.74, marking a decrease of 122.20.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 192.37. This value is within the healthy range. It has decreased from 200.53 (Jun 24) to 192.37, marking a decrease of 8.16.
- For PBIT / Share (Rs.), as of Mar 25, the value is 172.65. This value is within the healthy range. It has decreased from 175.17 (Jun 24) to 172.65, marking a decrease of 2.52.
- For PBT / Share (Rs.), as of Mar 25, the value is 170.04. This value is within the healthy range. It has decreased from 172.52 (Jun 24) to 170.04, marking a decrease of 2.48.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 128.16. This value is within the healthy range. It has increased from 126.33 (Jun 24) to 128.16, marking an increase of 1.83.
- For PBDIT Margin (%), as of Mar 25, the value is 28.05. This value is within the healthy range. It has increased from 24.81 (Jun 24) to 28.05, marking an increase of 3.24.
- For PBIT Margin (%), as of Mar 25, the value is 25.17. This value exceeds the healthy maximum of 20. It has increased from 21.68 (Jun 24) to 25.17, marking an increase of 3.49.
- For PBT Margin (%), as of Mar 25, the value is 24.79. This value is within the healthy range. It has increased from 21.35 (Jun 24) to 24.79, marking an increase of 3.44.
- For Net Profit Margin (%), as of Mar 25, the value is 18.68. This value exceeds the healthy maximum of 10. It has increased from 15.63 (Jun 24) to 18.68, marking an increase of 3.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 40.82. This value is within the healthy range. It has decreased from 42.38 (Jun 24) to 40.82, marking a decrease of 1.56.
- For Return on Capital Employeed (%), as of Mar 25, the value is 49.53. This value is within the healthy range. It has decreased from 53.26 (Jun 24) to 49.53, marking a decrease of 3.73.
- For Return On Assets (%), as of Mar 25, the value is 21.77. This value is within the healthy range. It has decreased from 22.48 (Jun 24) to 21.77, marking a decrease of 0.71.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.19. It has decreased from 1.41 (Jun 24) to 1.19, marking a decrease of 0.22.
- For Current Ratio (X), as of Mar 25, the value is 1.64. This value is within the healthy range. It has increased from 1.56 (Jun 24) to 1.64, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 1.04 (Jun 24) to 1.06, marking an increase of 0.02.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.26. This value is within the healthy range. It has decreased from 6.52 (Jun 24) to 5.26, marking a decrease of 1.26.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 85.81. This value exceeds the healthy maximum of 50. It has decreased from 106.84 (Jun 24) to 85.81, marking a decrease of 21.03.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 74.37. This value exceeds the healthy maximum of 50. It has decreased from 88.98 (Jun 24) to 74.37, marking a decrease of 14.61.
- For Earning Retention Ratio (%), as of Mar 25, the value is 14.19. This value is below the healthy minimum of 40. It has increased from -6.84 (Jun 24) to 14.19, marking an increase of 21.03.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 25.63. This value is below the healthy minimum of 40. It has increased from 11.02 (Jun 24) to 25.63, marking an increase of 14.61.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 73.67. This value is within the healthy range. It has decreased from 75.73 (Jun 24) to 73.67, marking a decrease of 2.06.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 50.08. This value is within the healthy range. It has increased from 48.71 (Jun 24) to 50.08, marking an increase of 1.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 25,719.18. It has increased from 23,131.91 (Jun 24) to 25,719.18, marking an increase of 2,587.27.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 11.51. This value exceeds the healthy maximum of 3. It has increased from 8.79 (Jun 24) to 11.51, marking an increase of 2.72.
- For EV / EBITDA (X), as of Mar 25, the value is 41.02. This value exceeds the healthy maximum of 15. It has increased from 35.40 (Jun 24) to 41.02, marking an increase of 5.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
- For Retention Ratios (%), as of Mar 25, the value is 14.18. This value is below the healthy minimum of 30. It has increased from -6.84 (Jun 24) to 14.18, marking an increase of 21.02.
- For Price / BV (X), as of Mar 25, the value is 25.55. This value exceeds the healthy maximum of 3. It has increased from 24.31 (Jun 24) to 25.55, marking an increase of 1.24.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 11.70. This value exceeds the healthy maximum of 3. It has increased from 8.97 (Jun 24) to 11.70, marking an increase of 2.73.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Jun 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Gillette India Ltd:
- Net Profit Margin: 18.68%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 49.53% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 40.82% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 50.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 44.9 (Industry average Stock P/E: 59.44)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.68%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | P&G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Anjuly Chib Duggal | Chairperson & Independent Director |
| Mr. Kumar Venkatasubramanian | Managing Director |
| Ms. Srividya Srinivasan | Executive Director & CFO |
| Mr. Srinivas Maruthi Patnam | Executive Director |
| Mr. Pramod Agarwal | Non Executive Director |
| Mr. Sanjay Asher | Independent Director |
| Mr. C P Gurnani | Independent Director |
FAQ
What is the intrinsic value of Gillette India Ltd?
Gillette India Ltd's intrinsic value (as of 10 January 2026) is ₹5410.30 which is 31.52% lower the current market price of ₹7,900.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹25,748 Cr. market cap, FY2025-2026 high/low of ₹11,505/7,412, reserves of ₹1,130 Cr, and liabilities of ₹2,149 Cr.
What is the Market Cap of Gillette India Ltd?
The Market Cap of Gillette India Ltd is 25,748 Cr..
What is the current Stock Price of Gillette India Ltd as on 10 January 2026?
The current stock price of Gillette India Ltd as on 10 January 2026 is ₹7,900.
What is the High / Low of Gillette India Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Gillette India Ltd stocks is ₹11,505/7,412.
What is the Stock P/E of Gillette India Ltd?
The Stock P/E of Gillette India Ltd is 44.9.
What is the Book Value of Gillette India Ltd?
The Book Value of Gillette India Ltd is 357.
What is the Dividend Yield of Gillette India Ltd?
The Dividend Yield of Gillette India Ltd is 1.42 %.
What is the ROCE of Gillette India Ltd?
The ROCE of Gillette India Ltd is 56.1 %.
What is the ROE of Gillette India Ltd?
The ROE of Gillette India Ltd is 41.6 %.
What is the Face Value of Gillette India Ltd?
The Face Value of Gillette India Ltd is 10.0.